Compare RVTY & IVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVTY | IVZ |
|---|---|---|
| Founded | 1937 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.5B |
| IPO Year | N/A | 1995 |
| Metric | RVTY | IVZ |
|---|---|---|
| Price | $100.25 | $26.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 16 |
| Target Price | ★ $112.31 | $22.97 |
| AVG Volume (30 Days) | 1.7M | ★ 5.0M |
| Earning Date | 01-30-2026 | 01-27-2026 |
| Dividend Yield | 0.28% | ★ 3.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.99 | 1.47 |
| Revenue | $2,813,367,000.00 | ★ $6,278,100,000.00 |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $3.07 | $12.38 |
| P/E Ratio | $50.39 | ★ $17.87 |
| Revenue Growth | 3.37 | ★ 6.64 |
| 52 Week Low | $81.36 | $11.60 |
| 52 Week High | $128.29 | $27.31 |
| Indicator | RVTY | IVZ |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 63.18 |
| Support Level | $98.73 | $23.97 |
| Resistance Level | $104.44 | $27.31 |
| Average True Range (ATR) | 3.04 | 0.79 |
| MACD | -0.19 | 0.23 |
| Stochastic Oscillator | 39.70 | 74.31 |
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of September 2025, the firm had $2.125 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 47% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).